ULK1/2 Inhibitors that Degrade ATG13 Effectively Target KRAS-Mutant Cancers is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Grant: 19-65-COSF
Curebound
Grant: 2022 Discovery Grant
Curebound
Grant: 2023 Discovery Grant 23TG05
National Cancer Institute
Grant: P30CA030199
National Cancer Institute
Grant: R35CA220538
National Cancer Institute
Grant: P01CA120964
National Cancer Institute
Grant: F32CA206400
Fields of Study
Keywords